Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) price closed lower on Monday, April 15, dropping -5.08% below its previous close.
A look at the daily price movement shows that the last close reads $1.97. The company’s 5Y monthly beta was ticking 1.27. Taking into account the 52-week price action we note that the stock hit a 52-week high of $3.79 and 52-week low of $0.92. The stock subtracted -23.05% on its value in the past month.
Lexicon Pharmaceuticals Inc, which has a market valuation of $460.47 million, is expected to release its quarterly earnings report Apr 30, 2024 – May 06, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give LXRX a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that LXRX’s price is at present -15.46% off the SMA20 and -21.63% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 37.76, with weekly volatility standing at 5.62%. The indicator jumps to 7.64% when calculated based on the past 30 days. Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s beta value is holding at 1.31, while the average true range (ATR) indicator is currently reading 0.18.
An analysis of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock in terms of its daily trading volume indicates that the 3-month average is 4.74 million.
Current records show that the company has 244.92M in outstanding shares. The insiders’ percentage holdings are 2.72% of outstanding shares while the percentage share held by institutions stands at 26.65%. But the 22.22% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
